Huntsman Cancer Institute (HCI) is a leader in the study of cancer genetics and its researchers have discovered more inherited cancer genes than any other cancer center in the world. Genes responsible for breast and ovarian cancer, colon cancer, head and neck cancer, and melanoma were identified here.

From its beginning, HCI has followed a “lab bench to patient bedside” research model. HCI is the only cancer center in the region that conducts basic, translational, and clinical research simultaneously, taking what’s learned in the laboratory through drug development and into the clinic.

Recent News

HCI Scientist Receives $1M Award to Fund Cancer Research

SALT LAKE CITY—Jody Rosenblatt, Ph.D., a cell biologist at Huntsman Cancer Institute and an associate professor of oncological sciences at the University of Utah has been selected as a Howard Hughes Medical Institute (HHMI) Faculty Scholar, HHMI announced today: https://www.hhmi.org/news/philanthropies-announce-selection-faculty-scholars. The award provides $1 million to fund her research over the course of five years.

Read More

A vaccine prevents cancer, yet few use it

Thousands of lives could be saved by a simple vaccination to protect against Human Papillomavirus (HPV). Yet only 51% of teens receive the vaccine each year. Every year more than four thousand people die from cancers related to HPV. It's upsetting, it's really upsetting,” says Deanna Kepka, PhD, MPH, a population scientist at Huntsman Cancer Institute (HCI). “If you ask any cancer survivor whether they would have taken an opportunity to get a vaccine that prevented their cancer, they would say yes.”

Read More

‘Liking’ Our Way to a Cure for Cancer

Researchers recently revealed in a Nature Genetics paper that they had identified a new gene linked to ALS, a neurodegenerative condition also known as Lou Gehrig’s disease. The July announcement was a milestone in the fight against ALS, which affects about 30,000 Americans, and a historic moment in financing disease research.

Read More

Insurance slow to 'catch up' with cancer drug as Utah man runs out of time

To look at 52-year-old Mark Wilson, actively keeping up with the high school baseball players he coaches, you'd never know that cancer is tearing his body apart. “It's a sarcoma,” Wilson said. “I was diagnosed with it in October of 1999." He has survived thanks to a strong disposition as well as the strong work of his doctors and nurses.

Read More